Honokiol and sophorolipid compound as well as preparation method and application thereof
The invention provides a honokiol and sophorolipid compound and a preparation method and application thereof. The honokiol and sophorolipid compound is formed by compounding honokiol and sophorolipid according to the mass ratio of 1: (6-8). The compound is obtained by adopting one of the following preparation modes: mode 1, dissolving honokiol and sophorolipid in an organic solvent I, then adding an organic mixed solution into an aqueous medium for mixing and emulsifying, removing the organic solvent I after micelles are formed, hydrating, and finally removing impurities; mode 2, dissolving honokiol and sophorolipid in an aqueous solution containing an organic solvent II, removing the organic solvent II after micelles are formed, hydrating, and finally removing impurities; mode 3, mixing and stirring honokiol, sophorolipid and water, and finally removing impurities; and mode 4, dissolving honokiol and sophorolipid in an aqueous solution containing an organic solvent III, dialyzing with water, and finally removing impurities from dialysate. Experiments show that the compound has a good biological membrane removal effect and a good bacteriostatic and antibacterial effect..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 05. Jan. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
FU HUALIN [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-01-05, Last update posted on www.tib.eu: 2024-04-30, Last updated: 2024-05-03 |
|---|
| Patentnummer: |
CN117338795 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA000881252 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA000881252 | ||
| 003 | DE-627 | ||
| 005 | 20240503110641.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240322s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA000881252 | ||
| 035 | |a (EPA)CN117338795 | ||
| 035 | |a (EPA)89370859 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a FU HUALIN |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Honokiol and sophorolipid compound as well as preparation method and application thereof |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-01-05, Last update posted on www.tib.eu: 2024-04-30, Last updated: 2024-05-03 | ||
| 520 | |a The invention provides a honokiol and sophorolipid compound and a preparation method and application thereof. The honokiol and sophorolipid compound is formed by compounding honokiol and sophorolipid according to the mass ratio of 1: (6-8). The compound is obtained by adopting one of the following preparation modes: mode 1, dissolving honokiol and sophorolipid in an organic solvent I, then adding an organic mixed solution into an aqueous medium for mixing and emulsifying, removing the organic solvent I after micelles are formed, hydrating, and finally removing impurities; mode 2, dissolving honokiol and sophorolipid in an aqueous solution containing an organic solvent II, removing the organic solvent II after micelles are formed, hydrating, and finally removing impurities; mode 3, mixing and stirring honokiol, sophorolipid and water, and finally removing impurities; and mode 4, dissolving honokiol and sophorolipid in an aqueous solution containing an organic solvent III, dialyzing with water, and finally removing impurities from dialysate. Experiments show that the compound has a good biological membrane removal effect and a good bacteriostatic and antibacterial effect. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a LI XIAOJUAN |e verfasserin |4 aut | |
| 700 | 0 | |a LIN SHIYU |e verfasserin |4 aut | |
| 700 | 0 | |a ZHANG WEI |e verfasserin |4 aut | |
| 700 | 0 | |a SHU GANG |e verfasserin |4 aut | |
| 700 | 0 | |a LIN JUCHUN |e verfasserin |4 aut | |
| 700 | 0 | |a XU FUNENG |e verfasserin |4 aut | |
| 700 | 0 | |a LI HAOHUAN |e verfasserin |4 aut | |
| 700 | 0 | |a PENG GUANGNENG |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 05. Jan. |
| 773 | 1 | 8 | |g year:2024 |g day:05 |g month:01 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/89370859/publication/CN117338795A1?q=CN117338795 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 05 |c 01 | ||